Specimen Collection and Handling

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

HOSPITAL ACQUIRED ANEMIA

IATROGENIC ANEMIA

ADDITIVE Light blue or blue

Sodium citrate

Light blue or blue Used for

coagulation studies (PT or PTT)

Used for coagulation studies (PT or PTT)

Light blue or blue

FOR routine chemistries, therapeutic drug levels, immunohematology, and serology

Red (Glass)

ADDITIVE Red (plastic)

Clot activator (silica)

for routine and special chemistry and cytogenetic testing

Green/Gray Light green

ADDITIVE Green/Gray Light green

Lithium Heparin and Gel separator

ADDITIVE Green

Lithium heparin Sodium Heparin

BEST ANTICOAGULANT FOR HEMOLYSIS PREVENTION; FOR STAT SAMPLE

Heparin

ADDITIVE Lavender (K3) Pink (K2)

EDTA/thylenediaminetetraacetate

Lavender (K3) Pink (K2)

hematology for complete blood count slide preparation routine hematology procedures\ immunohematology some special chemistry assays

Lavender (K3) Pink (K2)

EDTA increases

sodium potassium

EDTA decreases

calcium iron

ADDITIVE Gray

Sodium fluoride and Potassium oxalate Sodium Fluoride and EDTA Sodium fluoride

ADDITIVE Sodium fluoride and Potassium oxalate Sodium Fluoride and EDTA Sodium fluoride

Gray

Inhibits glycolysis

Gray

distorts rbc morphology

Sodium Fluoride & Oxalates

ADDITIVE Orange Gray/Yellow

Thrombin

Chem and toxicology

Royal Blue

ADDITIVE Tan (glass tube)

Sodium Heparin

ADDITIVE Tan (plastic)

EDTA

ADDITIVE Yellow

Sodium Polyanethol sulfonate (SPS)

Yellow

ADDITIVE Yellow

Acid Citrate Dextrose (ACD)

WBC preservative

Yellow

Tubes w/gel are not used for

ISBT2x IMMUNOLOGY AND SEROLOGY BLOOD BANKING TRACE METALS TDM - THERAPEUTIC DRUG MONITORING

Tube colors with EDTA

LRT PWD LAVENDER (glass and plastic) ROYAL BLUE TAN (PLASTIC) PINK WHITE D

Chelates calcium

● EDTA and Sodium Citrate ● All tubes with EDTA + Blue, Light blue

ADDITIVE Inhibits Thrombin formation

● Lithium Heparin ● Sodium Heparin

COLOR TOP Inhibits Thrombin formation

● Light green, green, black, royal blue

Clot activator

● Red (plastic/hemogard) (Silica) ● Red/gray and gold (Silica) ● Yellow/Gray and orange

Light blue ● Action:Fibrin ____________ product

DEGRADATION

● Action:Fibrin DEGRADATION product

Light blue

Yellow IS FOR?

● Blood bank (plasma) ● Microbiology (serum) ● HLA phenotyping ● Paternity testing

Which tube should not be used in Chemistry test? a) Red b) Lavander c) Yellow d) Mottled

b) Lavander

Outpatient - must provide ________ unique identifiers

TWO (e.g., name and date of birth)

most common way to collect blood

Venipuncture

Choice of venipuncture site:

Antecubital fossa

Order of Vein Choice:

MCB iii.Median iv.Cephalic v. Basilic

Most common Patterns of veins

M & H

MOST COMMON CHOICE , NOT ROLLING, LEAST PAINFUL, ANCHORED

Median

Cephalic

OBESE, FAT

NEAR THE CUTANEOUS NERVE & BRACHIAL ARTERY

Basilic

Use opposite arm or perform fingerstick, if possible; otherwise, have nurse turn off IV for __ min, apply tourniquet ________IV, use different vein (if possible).

2, BELOW

Extract below the IV site, initial HOW MANY ML IS DISCARDED?

5 ML

10% Contamination w/5% dextrose ฀Increase glucose in blood by

500 MG/DL

Vein Locating Device inspect an organ by passing light thru its wall

TRANSillumination

Vein Locating Device _____ or _____ light

LED, INFRARED

Apply the tourniquet and palpate using ? fingers to select the most appropriate collection site.

If Blood Pressure Cuff is used:INFLATE TO?

60 MMHG

tourniquet: prevent the spread of healthcare-acquire infection

Single-use

tourniquet: 3-4 inches ____ the (puncture) site

ABOVE

tourniquet: ?inches ABOVE the (puncture) site

3-4

Wait for __ min for 2nd attempt

The phlebotomist should never leave the tourniquet on the patient more than? minutes (new CLSI guideline – never more than ? min).

1-2 1

Antiseptic of choice:

70% alcohol

Cleanse the site with ____________________ which is more superior than circular

FRICTION, BACK AND FORTH

Site is allowed to dry FOR

30 SECS

For Ethanol testing: ___________ is used

BENZALKONIUM Chloride (Zephiran Chloride)

Needle should enter the site at a ________-degree angle, with the bevel of the needle facing up.

15-30

Needles are usually gauge

20 or 21

NEEDLE Length:_________________.

1-1.5 INCHES

Many phlebotomists believe that using a 1-inch needle gives better control and less _________ to the patient

FRIGHTENING

Never _____ (fishing)

PROBE

Traumatic Tap:

Ck,Myoglobin,& K

.If artery is hit, withdraw syringe, apply pressure for _______, ____the supervisor

5 MINS, CALL

Causes of Collapse vein i. too much _______ ii. quick ____ of plunger iii.tight __________ or close to the site of puncture

VACUUM PULL TOURNIQUET

Follow the order of draw

BLOOD CULTURE/ YELLOW CITRATE/ LIGHT BLUE/ BLUE RED (PLASTIC/GLASS) HEPARIN/GREEN EDTA/LAVENDER/PINK SODIUM FLOURIDE/GRAY

transfer of one additive/specimen to another thru needle contact causing contamination

CARRY OVER

MOST COMMON CAUSE OF CARRY OVER

EDTA

Remove the needle and then immediately apply pressure to the site using a gauze pad. FOR ?

15 MINS

means to detect errors and to minimize clerical errors

BAR code labels

– most common complication in blood

ECCHYMOSIS

– near the wrist bone

Tourniquet

Angle –

10-15o

PERSPIRATION BEADS, HYPERVENTILATE, LOSS OF COLOR

Fainting (syncope)

COLD COMPRESS TO HER FOREHEAD

Nausea or vomiting

blood vessel abnormality not the phlebo

Petechiae

Pediatric venipuncture – ___ loss of blood can lead to shock and cardiac arrest

10%

– 10% loss of blood can lead to shock and cardiac arrest

Pediatric venipuncture

Oxygenated (bright red color)

Arterial Puncture

Arterial Puncture Uses:

Blood gas and pH

Uses: Blood gas and pH

Arterial Puncture

Arterial Puncture Collected _____ tourniquet

WITHOUT

Collected WITHOUT tourniquet

Arterial Puncture

CONDUCTED PRIOR TO COLLECTION

Modified Allen test

Arterial Puncture DEGREES

45-60 DEGREES (90 DEGREES femoral)

Skin Puncture a. Length of Lancet:

1.75 MM

Skin Puncture Depth of incision: infants

<2.0mm

Skin Puncture Depth of incision: <2.0mm

infants

Skin Puncture Depth of incision: for adults

<2.5 mm

Skin Puncture Depth of incision: <2.5 mm for

adults

Preferred Sites – newborn

Lateral Plantar heel

Preferred Sites Palmar:

3rd and 4th fingers

Preferred Sites :LEAST SITE

Ear lobes

Preferred Sites Ear lobes:

LEAST SITE

Order of Filling microtainer

:GS EON i. Blood GAS analysis ii. SLIDES, unless made from specimen in the EDTA microcollection tube iii.EDTA iv.Other tubes w/additives v. Non additive tubes

100

Arterialized Capillary Blood a. For measuring

PH &PCO2

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前